Larvol Delta - ASLAN-Pharmaceuticals-to-CoHost-KOL-Panel-Discussion-on-Changes-in-the-Clinical-Trial-and-Treatment-Landscape-for-Atopic-Dermatitis

Dupixent (dupilumab) - Sanofi, Regeneron

eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings

https://www.globenewswire.com/news-release/2023/10/18/2762189/0/en/ASLAN-Pharmaceuticals-to-Co-Host-KOL-Panel-Discussion-on-Changes-in-the-Clinical-Trial-and-Treatment-Landscape-for-Atopic-Dermatitis.html

Oct 18, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next